OUTBREAK of novel corona virus disease (COVID-19): Antecedence and aftermath
- 1 October 2020
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 884, 173381
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirinScientific Reports, 2013
- Clinical outcome in resistant HIV-2 infection treated with raltegravir and maravirocAntiviral Research, 2010
- Identification of In Vivo-Interacting Domains of the Murine Coronavirus Nucleocapsid ProteinJournal of Virology, 2009
- Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse modelsVaccine, 2007
- A Severe Acute Respiratory Syndrome Coronavirus That Lacks the E Gene Is Attenuated In Vitro and In VivoJournal of Virology, 2007
- Architecture of the SARS coronavirus prefusion spikeNature Structural & Molecular Biology, 2006
- The role of melatonin in immuno‐enhancement: potential application in cancerInternational Journal of Experimental Pathology, 2006
- Modular organization of SARS coronavirus nucleocapsid proteinJournal of Biomedical Science, 2005
- HIV protease inhibitor ritonavir increases endothelial monolayer permeabilityBiochemical and Biophysical Research Communications, 2005
- In vitro inhibition of human cytomegalovirus replication by desferrioxamineAntiviral Research, 1994